-
EP3689876
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3689876
| EP3689876 - PDE9 INHIBITOR AND USE THEREOF [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 05.04.2024 Database last updated on 26.07.2024 | |
| Former | Request for examination was made Status updated on 03.07.2020 | ||
| Former | The international publication has been made Status updated on 06.04.2019 | Most recent event Tooltip | 24.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states TransThera Sciences (Nanjing), Inc. Floor 3, Building 9, Phase 2 Accelerator Biopharma Valley Jiangbei New Area Nanjing, Jiangsu 210000 / CN | [2023/16] |
| Former [2020/32] | For all designated states Nanjing Transthera Biosciences Co. Ltd. Floor 3, Building 9, Phase 2 Accelerator Biotech and Pharmaceutical Valley Jiangbei New Area Nanjing Jiangsu 210032 / CN | Inventor(s) | 01 /
WU, Frank Floor 3 Building 9 Phase 2 Accelerator Biotech and Pharmaceutical Valley, Jiangbei New Area Nanjing Jiangsu 210032 / CN | 02 /
LI, Lin Floor 3 Building 9 Phase 2 Accelerator Biotech and Pharmaceutical Valley, Jiangbei New Area, High-Tech District Nanjing Jiangsu 210032 / CN | 03 /
YANG, Xiaoju Floor 3 Building 9 Phase 2 Accelerator Biotech and Pharmaceutical Valley, Jiangbei New Area, High-Tech District Nanjing Jiangsu 210032 / CN | [2020/32] | Representative(s) | Icosa 83 avenue Denfert-Rochereau 75014 Paris / FR | [2020/32] | Application number, filing date | 18860570.3 | 26.09.2018 | [2020/32] | WO2018CN107461 | Priority number, date | CN201710900197 | 28.09.2017 Original published format: CN201710900197 | CN201810203538 | 13.03.2018 Original published format: CN201810203538 | CN201810871998 | 02.08.2018 Original published format: CN201810871998 | [2020/32] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019062733 | Date: | 04.04.2019 | Language: | ZH | [2019/14] | Type: | A1 Application with search report | No.: | EP3689876 | Date: | 05.08.2020 | Language: | EN | [2020/32] | Search report(s) | International search report - published on: | CN | 04.04.2019 | (Supplementary) European search report - dispatched on: | EP | 06.04.2021 | Classification | IPC: | C07D487/04, A61K31/55, A61K31/4545, A61K31/4375, A61K31/5377, A61K31/496, A61K31/519, A61P25/28, A61P25/18 | [2020/32] | CPC: |
C07D491/107 (EP,KR,US);
C07D471/04 (EP,CN,KR,US);
A61K31/4375 (EP,KR);
A61K31/438 (EP);
A61K31/4545 (EP);
A61K31/496 (EP,KR);
A61K31/519 (EP);
A61K31/5377 (EP,KR);
A61K31/55 (EP,KR);
A61K45/06 (KR);
A61P25/00 (EP,CN);
A61P25/18 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/32] | Title | German: | PDE9-INHIBITOR UND VERWENDUNG DAVON | [2020/32] | English: | PDE9 INHIBITOR AND USE THEREOF | [2020/32] | French: | INHIBITEUR DE PDE9 ET SON UTILISATION | [2020/32] | Entry into regional phase | 10.04.2020 | Translation filed | 28.04.2020 | National basic fee paid | 28.04.2020 | Search fee paid | 28.04.2020 | Designation fee(s) paid | 28.04.2020 | Examination fee paid | Examination procedure | 28.04.2020 | Examination requested [2020/32] | 22.10.2021 | Amendment by applicant (claims and/or description) | 09.04.2024 | Despatch of a communication from the examining division (Time limit: M04) | Request for further processing for: | 11.01.2022 | Request for further processing filed | 11.01.2022 | Full payment received (date of receipt of payment) | 11.01.2022 | Request for further processing filed | 11.01.2022 | Full payment received (date of receipt of payment) | 11.01.2022 | Request for further processing filed | 11.01.2022 | Full payment received (date of receipt of payment) | Fees paid | Renewal fee | 27.08.2020 | Renewal fee patent year 03 | 12.08.2021 | Renewal fee patent year 04 | 15.09.2022 | Renewal fee patent year 05 | 31.07.2023 | Renewal fee patent year 06 | 24.07.2024 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XA]EP1225173 (YAMANOUCHI PHARMA CO LTD [JP]); | [XA]US2007203236 (SMITH JEFFREY W [US], et al); |